Investing.com - Senti Biosciences reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Senti Biosciences announced earnings per share of $-0.380 on revenue of $1.77M. Analysts polled by Investing.com anticipated EPS of $-0.415 on revenue of $500K.
Senti Biosciences shares are down 4.96% from the beginning of the year and are trading at $2.480 , down-from-52-week-high.
Senti Biosciences shares gained 8.30% in intra-day trade the report.
Senti Biosciences follows other major Healthcare sector earnings this month
Senti Biosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar